No phaseRecruitingGeroscience intervention
Nicotinamide Riboside, Vit B3 Analogue, and Brain Energy Metabolism
The Effects of Nicotinamide Riboside Supplementation on Brain NAD+/NADH Ratio and Bioenergetics
- Sponsor
- Massachusetts General Hospital (Academic or other)
- Enrollment
- 50 planned
- Conditions
- Healthy Adult
- Interventions
- Niagen®
- Ages
- adults, older adults
- Registry
- NCT07649161
Full record on ClinicalTrials.gov
From the registry
The goal of this clinical trial is to learn how nicotinamide riboside (NR), a form of vitamin B3, affects brain energy metabolism in healthy adults. Researchers want to find out if taking NR by mouth for 2 weeks can raise the balance of two related brain chemicals called NAD+ and NADH, which play a key role in how cells make and use energy. The main questions are: Does short term NR treatment increase the NAD+ to NADH ratio in the brain, and does it change other brain energy measures that we can see with a special type of MRI scan called phosphorus 31 MR spectroscopy. Adults between 18 and 65 years old who are generally healthy and do not have a personal or close family history of mood or psychotic disorders may be able to take part. People who join the study will first have a screening visit with a psychiatric interview and safety checks to confirm they are eligible and to review the risks and procedures. Eligible participants will then have a baseline visit that includes a blood draw, vital signs, urine drug and pregnancy tests when needed, and a 7 Tesla MRI/MRS scan focused on…
Primary outcomes
- Brain NAD+/NADH Ratio
History
Study completion expected
Primary completion expected
Expected to start
Last registry update
Registered